EMEA-001146-PIP01-11-M07
Key facts
| Invented name |
Moventig
|
| Active substance |
Naloxegol
|
| Therapeutic area |
Gastroentology-Hepatology
|
| Decision number |
P/0493/2021
|
| PIP number |
EMEA-001146-PIP01-11-M07
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of opioid-induced constipation
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Kyowa Kirin Pharmaceutical Development Limited
Tel. +44 1896664000 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|